Artivion, Inc. Common Stock (NY:AORT)
All News about Artivion, Inc. Common Stock
This Analyst Says Artivion's Sell Off Seems Overdone After Trial Halt
September 26, 2022
Via Benzinga
Oppenheimer Maintains Outperform Rating for Artivion: Here's What You Need To Know
September 26, 2022
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
September 23, 2022
Via Benzinga
Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance
September 23, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.